Navigation Links
World Biotech API Market Potential Examined in New Topical Study Now Available at MarketPublishers.com
Date:6/20/2012

London, UK (PRWEB) June 20, 2012

The global API market has been advancing at a significant growth rate in recent times and it is likely to register a healthy CAGR of around 8% during 2012-2015, supported by factors such as emergence of India and China as prominent API manufacturing hub, patent expiration of blockbuster drugs and technological innovation to drive HPAPI segment, as well as impressive participation of private players.

Biotech APIs have a very low share in the global API market with synthetic APIs accounting for majority of the formulations. However, with the revolutionary growth in the biopharmaceutical industry and gaining applications of biotech drugs, biotech APIs are sure to see a highly prospective market in the future. The branded APIs currently dominate the biotech APIs market; however, with growing patent expiries and advancements in the market structure, the generic APIs will see a rapid growth.

New market research study “Global Biotech API Market Analysis” elaborated by RNCOS E-Services has been recently published by Market Publishers Ltd.

Report Details:

Title: Global Biotech API Market Analysis
Published: June, 2012
Pages: 60
Price: US$ 1,000.00
http://marketpublishers.com/report/medicine_pharmaceuticals_biotechnology/drugs_biotechnology/global_biotech_api_market_analysis.html

The study presents unbiased analysis and forecast for the biotech API market from a global perspective. It analyses the regulatory structure in the API and the biotech API market covering the mandates and guidelines for manufacturing, safety, and good manufacturing practices (GMP). The report also provides elaborate profiles the top companies involved in the biotech API business to gain insights on their overall business, biotech API functioning, recent activities, along with analysis of their strengths and weaknesses. Furthermore, prudent market segmentation and forecasts; the geographic analysis and regulatory overview can also be found in the review.

Companies discussed include: Bayer Pharma AG, Bayer Pharma AG, Boehringer Ingelheim, Hospira, Lonza, Ranbaxy Laboratories, Royal Dsm N.V., Sigma-Aldrich, Teva Active Pharmaceutical Ingredients, Zhejiang Hisun Pharmaceutical Co. Ltd.

Report Contents:

1. Analyst View

2. Research Methodology

3. Biotech Active Pharmaceutical Ingredients - an Introduction

4. Active Pharmaceutical Ingredient - Industry Performance

4.1 Current and Future Market Analysis to 2015
4.2 Branded and Generic APIs
4.3 Synthetic and Biotech APIs

5. Biotech Active Pharmaceutical Ingredients - Industry Performance

5.1 Current and Future Market Analysis to 2015
5.2 Biogeneric and Innovator Biotech APIs
5.3 Key Geographical Markets

6. Regulatory Environment

7. Competitive Landscape

7.1 Bayer Pharma AG
7.1.1 Business Overview
7.1.2 Strengths and Weaknesses
7.1.3 Recent Developments
7.2 Biocon Limited
7.2.1 Business Overview
7.2.2 Strengths and Weaknesses
7.2.3 Recent Developments
7.3 Boehringer Ingelheim
7.3.1 Business Overview
7.3.2 Strengths and Weaknesses
7.3.3 Recent Developments
7.4 Hospira
7.4.1 Business Overview
7.4.2 Strengths and Weaknesses
7.4.3 Recent Developments
7.5 Lonza
7.5.1 Business Overview
7.5.2 Strengths and Weaknesses
7.5.3 Recent Developments
7.6 Ranbaxy Laboratories
7.6.1 Business Overview
7.6.2 Strengths and Weaknesses
7.6.3 Recent Developments
7.7 Royal Dsm N.V.
7.7.1 Business Description
7.7.2 Strengths and Weaknesses
7.7.3 Recent Developments
7.8 Sigma-Aldrich
7.8.1 Business Overview
7.8.2 Strengths and Weaknesses
7.8.3 Recent Developments
7.9 Teva Active Pharmaceutical Ingredients
7.9.1 Business Overview
7.9.2 Strengths and Weaknesses
7.9.3 Recent Developments
7.10 Zhejiang Hisun Pharmaceutical Co. Ltd.
7.10.1 Business Overview
7.10.2 Strengths and Weaknesses
7.10.3 Recent Developments

List of Figures:

Figure 4-1: Global - API Market (Billion US$), 2011-2015
Figure 4-2: Global - Share of Captive and Merchant Market in API Market (2011)
Figure 4-3: Global - Share of Branded and Generic APIs in API Merchant Market (2011)
Figure 4-4: Global - Share of Synthetic and Biotech APIs in API Market (2011)
Figure 5-1: Global - Biotech API Market (Billion US$), 2011-2015
Figure 5-2: Global - Share of Biogeneric and Innovator APIs in Biotech API Market by (2011)
Figure 5-3: Global - Biotech API Market by Country (%), 2011

More new market research reports by the publisher can be found at RNCOS E-Services page.

Read the full story at http://www.prweb.com/releases/2012/6/prweb9623005.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Plasma etching pushes the limits of a shrinking world
2. Researching graphene nanoelectronics for a post-silicon world
3. Multidisciplinary team of researchers develop world’s lightest material
4. Hologic to Showcase 3D Mammography (Breast Tomosynthesis) and Other Advanced Womens Imaging Technologies at RSNA 2011, the Largest Radiology Show in the World
5. Researchers develop one of the worlds smallest electronic circuits
6. Janssen Biotech, Inc. Announces Collaborative Development and Worldwide License Agreement for Investigational Anti-Cancer Drug, PCI-32765
7. Experts Launch the Alliance for Fertility Preservation at the International Society for Fertility Preservations 2nd World Congress
8. The worlds smallest steam engine
9. StemCyte Adds World Class Talent to its North America and Global Operations
10. West Palm Beach, FL to Host 8th Annual World Stem Cell Summit December 3-5, 2012
11. U of Toronto experiment named top breakthrough of 2011 by Physics World
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... , ... April 29, 2016 , ... ... personalized pain medicine, is excited to announce the launch of the Proove ... health studies, volunteerism, and education to promote the use of personalized medicine for ...
(Date:4/29/2016)... , April 29, 2016 ... by Transparency Market Research "Separation Systems for Commercial ... Growth, Trends, and Forecast 2015 - 2023", the ... at US$ 10,665.5 Mn in 2014 and is ... from 2015 to 2023 to reach US$ 19,227.8 ...
(Date:4/29/2016)... ... April 29, 2016 , ... Summit for Stem Cell has received a ... a patient-specific stem cell therapy for the treatment of Parkinson’s disease. The Summit research ... at The Scripps Research Institute in San Diego, CA. , The aim ...
(Date:4/29/2016)... 2016 Elekta is pleased to ... its industry-leading treatment planning software, is available for clinical ... version 5.11 provides significant performance speed enhancements ... up to four times faster than in previous versions ... gold standard Monte Carlo algorithm, ...
Breaking Biology Technology:
(Date:3/14/2016)... March 14, 2016 NXTD ) ("NXT-ID" ... commerce market, announces the airing of a new series of ... week of March 21 st .  The commercials will air ... popular Squawk on the Street show. --> NXTD ... growing mobile commerce market, announces the airing of a new ...
(Date:3/10/2016)... 2016   Unisys Corporation (NYSE: UIS ) ... (CBP) is testing its biometric identity solution at the Otay ... to help identify certain non-U.S. citizens leaving the country. ... to help determine the efficiency and accuracy of using biometric ... will run until May 2016. --> the ...
(Date:3/3/2016)... 2016  FlexTech, a SEMI Strategic Association Partner, awarded ... & Development, Leadership in Education, and, in a category ... th year of the FLEXI Awards and the ... from past years . Judging was done on ... of criteria, by a panel of non-affiliated, independent, industry ...
Breaking Biology News(10 mins):